References
- Horlein D, Fietzek P P, Kuhn K, Pro-gln. The procollagen peptidase cleavage site in a1(1) chain of dermatosporactic calf skin procollagen. FEBS Lett 1978; 89: 279–282
- Prockop D J. Isotopic studies on collagen degradation and the urine excretion of hydroxyproline. J Clin Invest 1964; 43: 453–460
- Whitaker K B, Cox T M, Moss D W. An immunoassay of human band 5(“tartrate-resistant”) acid phosphatase that involves the use of anti-porcine uteroferrin antibodies. Clin Chem 1989; 35: 86–89
- Black D, Duncan A, Robins S P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 169: 197–203
- Eyre D R. Collagen cross-linking amino acids. Methods Enzymol 1987; 144: 115–139
- Pyridinium crosslinks as markers of bone resorption. Lancet 1992; 340: 278–279, Editorial.
- Hanson D A, Weis MA E, Bollen A M, Maslan S L, Singer F R, Eyre D R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992; 7: 1251–1258
- Bonde M, Qvist P, Fledelius C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994; 40: 2022–2025
- Eriksen E F, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res. 1993; 8: 127–132
- Kushida K, Takahashi M, Kawana K, Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects and osteoporosis patients. J Clin Endocrinol Metab 1995; 80: 2447–2450
- Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 3 1993; 9: 635–640
- Takahashi M, Ohishi T, Aoshima H, Kushida K, Inoue T, Horiuchi K. Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J Liq Chromatogr 1993; 16: 1355–1370
- Fujimoto D, Moriguchi T. Pyridinoline a non-reducible crosslink of collagen. J Biochem 1978; 83: 863–867
- Ohishi T, Takahashi M, Kawana K, et al. Age related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects. Clin Invest Med 1993; 16: 319–325
- Zweig M H, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–577
- Hanley J A, McNeil B J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29–36
- Uebelhart D, Schlemmer A, Johansen J S, Gineyts E, Christiansen C, Delmas P D. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 1991; 72: 367–373
- Bettica P, Moro L, Robins S P, et al. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992; 38: 2313–2318